ORIC(ORIC Pharmaceuticals, Inc.) · 财务报表

ORIC(ORIC Pharmaceuticals, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入—————
毛利润—————
营业利润−$78.87M−$91.77M−$110.78M−$142.90M−$143.00M
净利润−$78.72M−$89.12M−$100.70M−$127.85M−$129.47M
经营现金流−$59.54M−$75.14M−$85.69M−$112.66M−$110.97M
自由现金流−$60.48M−$77.22M−$86.54M−$113.85M−$111.68M
摊薄每股收益$-2.07$-2.25$-1.96$-1.83$-1.47

ORIC Pharmaceuticals, Inc. ORIC